Charles Schwab’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223M Buy
1,286,657
+78,898
+7% +$16.2M 0.03% 386
2025
Q4
$309M Buy
1,207,759
+50,403
+4% +$13.2M 0.05% 304
2025
Q3
$301M Buy
1,157,356
+66,378
+6% +$17.5M 0.05% 313
2025
Q2
$267M Buy
1,090,978
+45,129
+4% +$11.3M 0.05% 320
2025
Q1
$277M Buy
1,045,849
+80,923
+8% +$21.9M 0.05% 293
2024
Q4
$245M Buy
964,926
+65,735
+7% +$17.6M 0.05% 326
2024
Q3
$285M Buy
899,191
+26,056
+3% +$9.28M 0.05% 287
2024
Q2
$326M Buy
873,135
+52,781
+6% +$17.8M 0.06% 260
2024
Q1
$284M Buy
820,354
+2,314
+0.3% +$877K 0.07% 261
2023
Q4
$375M Buy
818,040
+26,879
+3% +$13.2M 0.1% 177
2023
Q3
$385M Sell
791,161
-514
-0.1% -$242K 0.11% 158
2023
Q2
$354M Sell
791,675
-427
-0.1% -$215K 0.1% 173
2023
Q1
$385M Buy
792,102
+6,569
+0.8% +$3.25M 0.12% 146
2022
Q4
$402M Buy
785,533
+23,038
+3% +$12.1M 0.13% 148
2022
Q3
$370M Buy
762,495
+19,085
+3% +$9.28M 0.13% 139
2022
Q2
$348M Buy
743,410
+471
+0.1% +$210K 0.12% 151
2022
Q1
$323M Buy
742,939
+27,173
+4% +$11.4M 0.1% 190
2021
Q4
$332M Buy
715,766
+17,218
+2% +$7.62M 0.1% 181
2021
Q3
$272M Sell
698,548
-417
-0.1% -$177K 0.09% 198
2021
Q2
$309M Buy
698,965
+21,092
+3% +$9.21M 0.1% 172
2021
Q1
$284M Buy
677,873
+766
+0.1% +$306K 0.1% 168
2020
Q4
$278M Buy
677,107
+2,962
+0.4% +$1.23M 0.11% 169
2020
Q3
$279M Buy
674,145
+4,581
+0.7% +$1.84M 0.13% 147
2020
Q2
$260M Sell
669,564
-1,662
-0.2% -$622K 0.13% 150
2020
Q1
$211M Buy
671,226
+19,316
+3% +$6.51M 0.12% 155
2019
Q4
$239M Buy
651,910
+3,560
+0.5% +$1.13M 0.13% 149
2019
Q3
$166M Buy
648,350
+22,627
+4% +$6.34M 0.1% 202
2019
Q2
$166M Buy
625,723
+15,767
+3% +$4M 0.1% 185
2019
Q1
$162M Buy
609,956
+5,161
+0.9% +$1.49M 0.1% 179
2018
Q4
$173M Buy
604,795
+6,579
+1% +$2.09M 0.13% 142
2018
Q3
$203M Buy
598,216
+15,478
+3% +$5.03M 0.13% 140
2018
Q2
$173M Buy
582,738
+6,522
+1% +$1.91M 0.13% 151
2018
Q1
$155M Sell
576,216
-76,886
-12% -$20.8M 0.12% 162
2017
Q4
$162M Sell
653,102
-79,119
-11% -$19.5M 0.13% 150
2017
Q3
$178M Buy
732,221
+82,857
+13% +$20.3M 0.16% 124
2017
Q2
$156M Buy
649,364
+131,124
+25% +$29.7M 0.15% 137
2017
Q1
$107M Sell
518,240
-2,171
-0.4% -$449K 0.11% 179
2016
Q4
$106M Buy
520,411
+18,136
+4% +$3.46M 0.12% 165
2016
Q3
$88.8M Buy
502,275
+15,205
+3% +$2.64M 0.1% 183
2016
Q2
$87.6M Buy
487,070
+12,914
+3% +$2.29M 0.11% 177
2016
Q1
$86.7M Sell
474,156
-11,834
-2% -$2.05M 0.11% 167
2015
Q4
$86.8M Buy
485,990
+9,413
+2% +$1.65M 0.12% 163
2015
Q3
$85.3M Buy
476,577
+44,651
+10% +$8.25M 0.13% 156
2015
Q2
$82.6M Buy
431,926
+13,535
+3% +$2.51M 0.11% 173
2015
Q1
$74.5M Buy
418,391
+12,197
+3% +$1.93M 0.1% 187
2014
Q4
$58.3M Buy
406,194
+12,448
+3% +$1.7M 0.09% 230
2014
Q3
$51.3M Buy
393,746
+10,013
+3% +$1.27M 0.08% 231
2014
Q2
$49M Buy
383,733
+5,312
+1% +$629K 0.08% 239
2014
Q1
$42.7M Sell
378,421
-21,763
-5% -$2.27M 0.08% 249
2013
Q4
$41.3M Buy
400,184
+4,545
+1% +$445K 0.08% 240
2013
Q3
$37.7M Buy
395,639
+23,445
+6% +$2.15M 0.08% 243
2013
Q2
$31.7M Buy
+372,194
New +$29.4M 0.07% 268

Other funds holding HUM

Charles Schwab's HUM Position: Q1 2026 in Review

Charles Schwab increased its Humana (HUM) stake by 6.5% in Q1 2026, buying an estimated $16.2M and bringing the position to 1,286,657 shares worth $223M. The position accounts for 0.03% of the portfolio, ranked #386.

Charles Schwab first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $402M in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Charles Schwab held 1,286,657 shares of Humana worth $223M as of Q1 2026.
  • Charles Schwab bought 78,898 Humana shares in Q1 2026, an estimated $16.2M.
  • Humana made up 0.03% of Charles Schwab's portfolio in Q1 2026, its #386 holding.
  • Charles Schwab first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Humana position peaked at $402M in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.